iShares Neuroscience and Healthcare ETF Rating $23.29 +0.57 (+2.51%) As of 05/2/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock iShares Neuroscience and Healthcare ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBRN Aggregate RatingModerate Buy 2.83Holdings in IBRN have an aggregate rating of Moderate Buy based on 388 analyst ratings issued in the past year covering 40 companies (81.0% of the portfolio).IBRN Aggregate Price Target$23.29High Prediction$23.29Average Prediction$23.29Low Prediction$23.29Holdings in IBRN have an aggregate price target of $23.29 and a range of $23.29 to $23.29 covering 40 companies (81.0% of the portfolio).IBRN Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy24 Buy rating(s)Moderate Buy12 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Neuroscience and Healthcare ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 40 IBRN Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.98%CPRXCatalyst Pharmaceuticals$24.84+2.3%4.6993 of 5 stars3.13$32.29 30.0%8Upcoming EarningsPositive News4.84%ARGXargenx$649.67+1.5%2.5642 of 5 stars2.91$699.28 7.6%23Upcoming EarningsNews CoveragePositive NewsGap Up4.79%XENEXenon Pharmaceuticals$38.28+0.5%2.6377 of 5 stars3.00$56.78 48.3%10Upcoming EarningsAnalyst DowngradeOptions VolumeNews CoveragePositive NewsHigh Trading Volume4.50%DNLIDenali Therapeutics$16.44+2.4%4.0803 of 5 stars3.06$37.57 128.5%17Upcoming EarningsPositive NewsGap Up4.38%PTCTPTC Therapeutics$49.95+0.9%3.9347 of 5 stars2.53$63.92 28.0%15Upcoming EarningsAnalyst RevisionNews CoveragePositive News4.36%NBIXNeurocrine Biosciences$109.68+2.9%4.9151 of 5 stars2.86$160.90 46.7%224.07%SRRKScholar Rock$32.91+0.5%3.9722 of 5 stars3.00$42.67 29.6%6Upcoming EarningsInsider TradeNews CoveragePositive News4.05%SUPNSupernus Pharmaceuticals$32.84+1.2%2.4455 of 5 stars2.33$36.00 9.6%3Upcoming Earnings3.86%ACADACADIA Pharmaceuticals$14.91+2.3%4.2579 of 5 stars2.50$23.87 60.1%16Upcoming EarningsAnalyst Revision3.76%ALKSAlkermes$31.78+3.9%4.1827 of 5 stars2.67$38.33 20.6%12Earnings ReportAnalyst ForecastNews Coverage3.66%BIIBBiogen$123.53+2.2%4.7044 of 5 stars2.38$195.85 58.5%32Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage3.37%BHVNBiohaven$22.76+1.4%3.7887 of 5 stars3.07$62.54 174.8%15Upcoming EarningsGap Up2.76%SRPTSarepta Therapeutics$63.51+1.2%4.7683 of 5 stars2.83$157.95 148.7%23Upcoming EarningsPositive News2.60%IARTIntegra LifeSciences$16.85+2.5%4.1355 of 5 stars1.89$22.71 34.8%9Upcoming EarningsNews CoverageGap Up2.48%EWTXEdgewise Therapeutics$16.91+1.4%3.1267 of 5 stars2.78$40.22 137.9%9Upcoming EarningsAnalyst ForecastShort Interest ↑News CoveragePositive News2.23%DYNDyne Therapeutics$11.86-1.1%3.4144 of 5 stars3.07$47.46 300.2%15Short Interest ↑News CoveragePositive News1.86%AVXLAnavex Life Sciences$9.36+0.5%3.9294 of 5 stars3.33$44.00 370.1%3Upcoming EarningsNews Coverage1.82%AVDLAvadel Pharmaceuticals$8.69+0.9%2.5624 of 5 stars3.00$19.88 128.7%8Upcoming EarningsNews CoveragePositive NewsGap Up1.60%PRAXPraxis Precision Medicines$40.24+5.7%3.2507 of 5 stars2.78$123.33 206.5%9Earnings ReportAnalyst ForecastNews Coverage1.59%AXGNAxoGen$17.13+3.9%3.001 of 5 stars3.00$22.60 31.9%5Upcoming EarningsPositive News1.20%CAPRCapricor Therapeutics$11.86-6.9%1.7813 of 5 stars3.00$34.50 190.9%6News CoveragePositive News0.99%DNTHDianthus Therapeutics$21.701.7168 of 5 stars3.22$54.33 150.4%9Upcoming EarningsNews CoveragePositive News0.96%PRTAProthena$8.50-2.5%3.6925 of 5 stars2.75$55.00 547.1%8Upcoming EarningsInsider TradeNews CoveragePositive NewsHigh Trading Volume0.96%RGNXREGENXBIO$10.40+5.8%4.4844 of 5 stars2.83$31.63 204.1%6Upcoming EarningsNews CoveragePositive News0.89%ZVRAZevra Therapeutics$8.00+4.7%2.7595 of 5 stars3.11$22.29 178.6%9Upcoming EarningsNews CoveragePositive News0.83%CLPTClearPoint Neuro$14.43+3.7%2.4043 of 5 stars3.00$25.00 73.3%3News CoveragePositive News0.77%CBLLCeriBell$16.32+0.2%2.2827 of 5 stars3.00$32.50 99.1%7News Coverage0.76%AMLXAmylyx Pharmaceuticals$5.32+3.5%3.0682 of 5 stars2.86$8.00 50.4%7Upcoming EarningsNews Coverage0.67%TSHATaysha Gene Therapies$2.58+7.1%1.9863 of 5 stars3.00$6.63 156.8%8News CoverageGap UpHigh Trading Volume0.62%NPCENeuroPace$11.98+1.6%3.6632 of 5 stars2.80$15.20 26.9%5Upcoming EarningsShort Interest ↓Positive News0.60%NGNENeurogene$16.97+10.2%2.0474 of 5 stars3.14$47.20 178.1%7Upcoming EarningsNews CoveragePositive News0.55%VNDAVanda Pharmaceuticals$4.57+2.9%4.2258 of 5 stars3.00$16.50 261.1%2Upcoming EarningsShort Interest ↑News Coverage0.53%DRUGBright Minds Biosciences$32.17+5.1%3.3617 of 5 stars3.20$84.33 162.1%5News CoveragePositive NewsGap Up0.49%ABEOAbeona Therapeutics$6.56-4.5%3.7439 of 5 stars3.00$18.75 185.8%4Analyst ForecastShort Interest ↑Analyst RevisionNews CoverageHigh Trading Volume0.48%RAPPRapport Therapeutics$11.33-1.2%2.5076 of 5 stars3.00$32.67 188.3%4Gap Up0.47%TRDAEntrada Therapeutics$9.23+2.0%3.001 of 5 stars3.25$25.67 178.1%4Upcoming EarningsNews Coverage0.46%SLDBSolid Biosciences$4.31+18.1%3.8173 of 5 stars3.33$15.67 263.5%12News CoverageHigh Trading Volume0.43%ANNXAnnexon$1.97+6.2%2.0829 of 5 stars3.00$18.67 847.5%40.42%FULCFulcrum Therapeutics$5.62+28.3%1.966 of 5 stars2.11$8.63 53.5%9Earnings ReportNews CoverageHigh Trading Volume0.38%VYGRVoyager Therapeutics$3.64+2.5%4.593 of 5 stars3.11$13.97 283.7%9 This page (NYSEARCA:IBRN) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Neuroscience and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Neuroscience and Healthcare ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IBRN Stock Free IBRN Stock Alerts